Skip to content

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges

Regulation of Extracellular Sodium in End Stage Renal Disease Upon Volume and Electrolyte Challenges - a Prospective Trial.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06408077
Acronym
RESERVE
Enrollment
60
Registered
2024-05-09
Start date
2023-07-01
Completion date
2026-05-31
Last updated
2025-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyponatremia

Keywords

hyponatremia, prospective trial, intracellular measurements, Water-Electrolyte Imbalance

Brief summary

Hyponatremia is the most common electrolyte disorder of all and can be observed in more than 30% of all patients in hospitals. Osmotic homeostasis of body fluids is essential for survival of all living creatures. It is widely accepted that extra- and intracellular osmolalities are in equilibrium at all times and thus, changes in the extracellular osmolality will lead to either shrinkage or swelling of cells which can be detrimental. In severe cases, it can lead to swelling of the brain and death. Even in less dramatic scenarios, symptoms such as epileptic seizures, headaches, depression and dizziness exist, leading to an increased risk of fractures, hospital admissions and a considerable burden for affected patients. As short-term defense against osmotic stress, each individual cell is capable of actively externalizing or internalizing osmotically active solutes which restores normal or near-normal cell volume at the expense of an altered milieu interior. Obviously, there must be limitations to this strategy if intracellular integrity is meant to be kept stable. It has therefore been postulated that, apart from this cell-immanent mechanism, extracellular and intracellular electrolyte stores could assist in buffering osmotic imbalances. The Edelman formula states that extracellular sodium is determined by the total amount of exchangeable body sodium (the major extracellular cation) plus potassium (the major intracellular cation) divided by total body water. Several studies have shown, that it only partially explains the changes in patients outside the osmotic equilibrium. To better understand these physiological responses might not only promote the researcher's insight into the most basic cellular self-defense systems by measuring and comparing extra- and intracellular electrolyte concentrations with estimated changes in a patient that will be intravenously challenged with either water or sodium chloride 3%. The evolution over time of extra- and intracellular sodium and other electrolytes will be assessed quantitatively in patients with impaired renal function after water or sodium chloride (NaCl) administration.

Interventions

Intravenous administration of water (Aqua ad injectabilia) until a decrease of plasma sodium of 5 to 8 mmol/l has been achieved

OTHERNaCl-Administration

Intravenous administration of NaCl 3% until an increase of plasma sodium of 5 to 8 mmol/l has been achieved

Sponsors

University of Cologne
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients ≥18 years * Requirement of renal replacement therapy due to surgical (i.e., nephrectomy) or non-surgical (chronic kidney disease) reason * Stable hemodialysis treatment for at least 3 months * Urine output \<100ml in 24 hours * Glucose-corrected plasma sodium between 135 mmol/l and 145 mmol/l * Plasma potassium between 3.5 mmol/l and 5 mmol/l * Written informed consent

Exclusion criteria

* Peritoneal dialysis patients * Signs of volume expansion or contraction * Congestive heart failure (NYHA ≥2) * acute illness (infection, congestive heart failure, liver cirrhosis, etc.) requiring hospital admission * Uncontrolled arterial hypertension * Hemoglobin ≤8g/dL * Alcohol abuse * Malnutrition * Persons, who are in a dependency/employment relationship with the investigators * Accommodation in an institution by judicial or administrative order

Design outcomes

Primary

MeasureTime frameDescription
acute changes of extracellular osmolality300 minutes after infusionThe primary aim is to compare the actual acute change of extracellular sodium with the estimated change of extracellular sodium in response to an intravenous challenge with either water or sodium. Precise evaluation of the validity of the concept of Edelman in acute changes of extracellular osmolality

Secondary

MeasureTime frameDescription
change of extracellular electrolyte concentrations300 minutes after infusionextracellular electrolyte concentrations in response to an intravenous challenge with either water or sodium.
change of intracellular electrolyte concentrations300 minutes after infusionintracellular (red blood cells/white blood cells) electrolyte concentrations in response to an intravenous challenge with either water or sodium.
change of osmolality300 minutes after infusionchange of osmolality in response to an intravenous challenge with either water or sodium
change of cell volume300 minutes after infusioncell volume (red blood cells) in response to an intravenous challenge with either water or sodium

Countries

Germany

Contacts

Primary ContactVolker Burst, MD
volker.burst@uk-koeln.de+49 221 478 86285
Backup ContactSadrija Cukoski, MD
sadrija.cukoski@uk-koeln.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026